Product Information
MESALAMINE DR 1.2 GM TABLET is a generic product labeled by American Health Packaging, priced at $0.8138 per EA under NDC 60687039725. Its NADAC has been published 391 times since Jan 2, 2019.
Strength
1.2 g/1
Manufacturer
American Health PackagingNDC
60687039725
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA091640On Market Since
10/11/2018
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE DR 1.2 GM TABLET has been published 391 times since Jan 2, 2019, and over the history we have for it it has declined 83.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8138 per EA |
|---|---|
| All-time high | $5.0208 (Jan 16, 2019) |
| All-time low | $0.8138 (Jun 17, 2026) |
| 52-week high | $1.1318 |
| 52-week low | $0.8138 |
| Median price | $2.5217 |
| Average price | $2.4434 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 391 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE DR 1.2 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 1.2 GM TABLET, manufactured by American Health Packaging, is $0.8138 per EA (NDC 60687039725), effective Jun 24, 2026.
How has the price of MESALAMINE DR 1.2 GM TABLET changed over time?
Over the history we have for it, the NADAC for MESALAMINE DR 1.2 GM TABLET has declined 83.8%. It has been tracked across 391 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for MESALAMINE DR 1.2 GM TABLET?
Since Jan 2, 2019, the NADAC for MESALAMINE DR 1.2 GM TABLET has ranged from a low of $0.8138 (Jun 17, 2026) to a high of $5.0208 (Jan 16, 2019), with a median of $2.5217 per EA.
Are there cheaper alternatives to MESALAMINE DR 1.2 GM TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE DR 1.2 GM TABLET, but none are currently priced below it.
Who manufactures MESALAMINE DR 1.2 GM TABLET?
MESALAMINE DR 1.2 GM TABLET (NDC 60687039725) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification